Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

anlotinib 3 Injections 3 Doxorubicin 3 toripalimab 1 spartalizumab 1 penpulimab 1 pemigatinib 1 pazopanib 1 montelukast 1 liposomal doxorubicin 1 eribulin 1 chlorhexidine gluconate 1 camrelizumab 1 bexmarilimab 1 apatinib 1 X-Rays 1 Trabectedin 1 Temozolomide 1 Tablets 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Radiotherapy 1 Proton Therapy 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Neoadjuvant Therapy 1 Negative-Pressure Wound Therapy 1 KP 1339 1 Ipilimumab 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Sarcoma × penpulimab × Clear all

NCT07612098 2026-05-28

SPARE-04

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡